Pittsburgh-based CytoAgents with Covid innovation starts clinical trials

14Oct

Pittsburgh-based CytoAgents with Covid innovation starts clinical trials

Portfolio News
CytoAgents, a Pittsburgh-based pharmaceutical company whose drug candidate battles a deadly side effect of respiratory illnesses like Covid-19, has reached the phase-one clinical trial stage. Read more >>

Share this post

Related Posts

04May

Single-cell protein meal may support production, survival of rainbow trout

Diets supplemented with single-cell protein meal may support farmed trout production, feed efficiency and boost survival rates, says researcher. Read... read more
10Apr

From ‘Shark Tank’ to the pandemic Framingham’s DetraPel steps up in coronavirus fight

Framigham’s DetraPel is donating disinfectant, hand sanitizers to community organizations. The company has grown significantly since founder David Zamarin showed... read more
08Jun

Regroup partners with Inova Solutions to offer emergency digital signage messaging

Regroup Mass Notification, an emergency notification company, is partnering with Inova Solutions, a visual emergency communication provider, to facilitate messaging... read more
02May

Myomo® Announces New Distribution Agreement for Australia / New Zealand

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb... read more
22Jun

Corbus Pharmaceuticals Announces Resolution of Inflammation, Infection and Tissue Regeneration Conference

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
14Mar

Myomo Reports Fourth Quarter and Full Year 2022 Financial Result

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
06Mar

Emovi is accelerating its growth through a 15M$ Series C investment led by TVM Capital Life Science

Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its... read more
03Dec

ZetrOZ Systems Expands Patient Access for Sustained Acoustic Medicine Treatment

ZetrOZ's sam® is the only FDA-cleared, long-duration, home-use, ultrasound treatment system, with over 30 peer-reviewed studies showing it effectively increases... read more
11Jul

Special glasses would give legally blind woman sight

On a Tuesday, Natasha Sokol's friend told her about eSight glasses, eyewear that helps people who are legally blind see... read more
02Oct

Oncocyte Agrees to Enter Licensing and Collaboration Agreement with Chronix Biomedical

Oncocyte Corporation, a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer... read more